Cardiovascular Diseases

818 trials 341 recruiting

Filter these 818 trials by phase, country and sponsor.

Open in Search →

MK-2060 Global Study in Patients with End Stage Renal Disease Receiving Hemodialysis Ended

2024-511055-17-00 Prevention of arteriovenous graft thrombosis 4 2021-11-25
VIRTUOSE: Efficiency of sildenafil on the absolute claudication distance of peripheral arterial disease patients with intermittent claudicat… Ended

2024-516429-30-00 Peripheral arterial disease 5 2021-11-24
An open-label, prospective, single centre study of the effects of Riociguat on RIght VEntricular size and function in Pulmonary Arterial Hyp… Ended

2023-509696-17-00 Chronic Thromboembolic Pulmonary Hypertension 6 2021-11-05
A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) Ended

2022-500881-80-00 Chronic Heart Failure With Reduced Ejection Fraction 5 2021-10-29
A trial to learn how well finerenone works and how safe it is in adult participants with non-diabetic chronic kidney disease Ended

2023-506897-11-00 Non-diabetic chronic kidney disease 5 2021-10-18
The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients. (EVATRAN) Ended

2024-513808-34-00 kidney transplantation 5 2021-10-12
Efficacy of Tocilizumab in association to steroids in giant cell arteritis with cerebro-vascular involvement patients (ToGiAS). A french pro… Ended

2024-511906-21-00 Giant cell arteritis with Cerebro-vascular involvement 5 2021-09-24
Myocarditis Therapy with IL-1 inhibitor (MYTH-1): a double-blind, phase IIa, placebo-controlled, randomized clinical trial to evaluate the e… Ended

2024-515472-13-00 endomyocardial biopsy (EBM)-proven virus-negative myoca 4 2021-09-23
PROgnostic value of precision medicine in patients with Myocardial Infarction and non-obStructive coronary artEries: the PROMISE study Ended

2024-518724-72-00 Myocardial infarction with non-obstructive coronary art 6 2021-09-02
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure (OPRA-HF) Ended

2024-511502-24-02 High-risk hyperkalemia 4 2021-08-18
The COlchicine HypERtENsion Trial Ended

2024-511391-32-00 Cardiovascular disease 4 2021-08-10
Dual Antithrombotic Therapy with Dabigatran and Ticagrelor in Patients with Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Und… Ended

2024-515056-20-00 Acute Coronary Syndrome and Non-valvular Atrial Fibrill 5 2021-07-31
A Phase I Randomised Double-Blind Placebo Controlled Safety Study of Intramyocardial Injection of CLXR-001 in Patients Undergoing Coronary A… Ended

2024-518524-69-00 Ischaemic cardiomyopathy 1 2021-07-30
Metoprolol Safety and Efficacy in the Prevention of Cardiomyopathy in Patients with Duchenne Muscular Dystrophy (DMD) Ended

2024-515057-19-00 Duchenne muscular dystrophy; Cardiomyopathy; Tachycardi 5 2021-07-12
A study designed to evaluate a modified Anti-Platelet Therapy (drugs that preventblood platelets from clotting) after implantation of a Fire… Ended

2024-519854-35-00 Acute Myocardial Infarction 6 2021-06-29
A Study of the Efficacy and Safety of MK-5475 in Participants with Pulmonary Arterial Hypertension Ended

2022-500877-15-00 Pulmonary arterial hypertension (PAH) in one of the fol 10 2021-06-25
Investigation to assess the effects of zalunfiban in patients with an acute heart attack Ended

2023-508485-15-00 Subjects with documented STEMI, presenting with persist 5 2021-04-22
First time in human clinical test using a personalized tissue-engineered blood vessel to treat chronical illness in a vein. Ended

2024-520148-40-00 Chronic venous insufficiency 1 2021-02-25
Randomized double-blind trial to study the benefit of Colchicine in Patients with Acutely Decompensated Heart Failure Ended

2023-504165-23-00 Acute decompensated heart failure 5 2021-02-08
Heart Failure study with Danicamtiv in patients with reduced heart function caused by gene mutation Ended

2023-505492-68-00 Primary Dilated Cardiomyopathy Due to Either MYH7 o TTN 4 2020-10-06
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CV… Ended

2023-507846-96-00 Type 2 Diabetes Mellitus 5 2020-06-19
Efficacy and safety of alirocumab to prevent early cardiac allograft vasculopathy in recent heart transplant recipients Ended

2024-514023-42-00 Cardiac allograft vaculopathy in recent heart transplan 6 2019-11-27
A study to Evaluate Patisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy Ended

2023-508364-29-00 Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amy 5 2019-11-22
A Long-term Safety Extension Study of Mavacamten (MYK-461) in Adults with Hypertrophic Cardiomyopathy Who Have Completed the MAVERICKHCM (MY… Ended

2022-502858-14-00 Hypertrophic cardiomyopathy 5 2019-09-05